Cipla
Anjal Jain serves as Senior Manager of Business Development and Growth at Cipla since February 2022, focusing on acquiring new business through out-licensing and CMO opportunities within the EU market. Prior experience includes a role as Senior Manager of Business Development and Operations at Cipla, where responsibility included driving growth and managing existing business in Western Europe. Anjal's career also features positions at Piramal Pharma Solutions as Manager of Established Products and Manager of Lead Generation/Inside Sales, contributing to significant business development efforts across the USA and Ex-USA. Earlier experience includes roles at MACLEODS PHARMACEUTICALS LTD., where Anjal handled product launches and brand management, and a summer internship at Sanofi, focused on evaluating the CNS market in Indian metro cities. Anjal holds an MBA in Pharmaceutical Marketing and Management from SVKM's Narsee Monjee Institute of Management Studies and a B.Tech. in Biotechnology from DY Patil University.
This person is not in any teams
This person is not in any offices
Cipla
19 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.